[Auditory evoked potentials from brain stem determined in acoustic nerve neurinomas].

Neurol Neurochir Pol

Katedry i Kliniki Otolaryngologii AM we Wrocławiu.

Published: July 1999

An analysis of the studies of Brain Stem Electric Response Audiometry of patients operated on Bachaumont Clinic or in Cochin hospital in Paris, because of acoustic neurinoma, was carried out. The studies comprised 88 patients divided into groups according to the size of tumour. A group of small intrameatal tumours, a group of up to 2 cm tumours, a group of between 2 and 3 cm tumours and a group of above 3 cm tumours. A control group of examined patients consisted of 20 persons with one-side acoustic impairment or two-side impairment but predominant on one side and patients with one-side tinnitus or two-side tinnitus but predominant on one side. Examinations of these patients made with CT and NMR did not show presence of acoustic neurinoma. BERA's tests did not show a response in case of 22 patients with acoustic neurinoma. In 71% of cases BERA's tests showed an extrahelix type, for which in 50% of cases a prolonged latency on the side of the tumour was found. In 4% of cases Brain Stem Electric Response Audiometry gave results within normal range both with respect to morphology and latency time of each wave. A slight correlation between the size of tumour and type of BERA change was found.

Download full-text PDF

Source

Publication Analysis

Top Keywords

brain stem
12
acoustic neurinoma
12
tumours group
12
group tumours
12
stem electric
8
electric response
8
response audiometry
8
size tumour
8
predominant side
8
bera's tests
8

Similar Publications

Sarcopenia is defined as a muscle-wasting syndrome that occurs with accelerated aging, while cachexia is a severe wasting syndrome associated with conditions such as cancer and immunodeficiency disorders, which cannot be fully addressed through conventional nutritional supplementation. Sarcopenia can be considered a component of cachexia, with the bidirectional interplay between adipose tissue and skeletal muscle potentially serving as a molecular mechanism for both conditions. However, the underlying mechanisms differ.

View Article and Find Full Text PDF

Mucopolysaccharidosis type I (MPS I) is a metabolic disorder characterized by a deficiency in α-l-iduronidase (IDUA), leading to impaired glycosaminoglycan degradation. Current approved treatments seek to restore IDUA levels via enzyme replacement therapy (ERT) and/or hematopoietic stem cell transplantation (HSCT). The effectiveness of these treatment strategies in preventing neurodegeneration is limited due to the inability of ERT to penetrate the blood-brain barrier (BBB) and HSCT's limited CNS reconstitution of IDUA levels.

View Article and Find Full Text PDF

Structural changes involving new neurons can occur through stem cell-driven neurogenesis and late-maturing immature neurons, namely undifferentiated neuronal precursors frozen in a state of arrested maturation. The latter exist in the cerebral cortex, being particularly abundant in large-brained mammals. Similar cells have been described in the amygdala of some species, although their interspecies variation remain poorly understood.

View Article and Find Full Text PDF

Unlabelled: The neurodegenerative disorder Frontotemporal Dementia (FTD) can be caused by a repeat expansion (GGGGCC; G4C2) in C9orf72. The function of wild-type C9orf72 and the mechanism by which the C9orf72-G4C2 mutation causes FTD, however, remain unresolved. Diverse disease models including human brain samples and differentiated neurons from patient-derived induced pluripotent stem cells (iPSCs) identified some hallmarks associated with FTD, but these models have limitations, including biopsies capturing only a static snapshot of dynamic processes and differentiated neurons being labor-intensive, costly, and post-mitotic.

View Article and Find Full Text PDF

encodes a UDP-galactose transporter essential for glycosylation of proteins and galactosylation of lipids and glycosaminoglycans. Germline genetic variants have been identified in congenital disorders of glycosylation and somatic variants have been linked to intractable epilepsy associated with malformations of cortical development. However, the functional consequences of these pathogenic variants on brain development and network integrity remain elusive.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!